Dr. Carolyn Schwartz is President & Chief Scientist at the not-for-profit DeltaQuest Foundation and Adjunct Research Professor of Medicine and Orthopaedic Surgery at the Tufts University School of Medicine. The 2016 recipient of the International Society for Quality of Life Research (ISOQOL) President's Award and ISOQOL Honorary Member since 2018, her interdisciplinary and methodological research focuses on understanding what patients can do to have an impact on the course of their disease and their well-being. In addition to development of theory and methods for response-shift research in quality of life, her work has spanned a number of diseases and conditions, and she has developed over 20 PRO measures. Dr. Schwartz earned a Bachelor's degree Magna Cum Laude in Psychology from UCLA, a Master's degree in Clinical Psychology at the University of Connecticut, and a Doctor of Science degree (Sc.D.) from the Harvard Chan School of Public Health with an emphasis on Behavioral Sciences, Biostatistics, and Immunology/Cancer Biology. She did her postdoctoral training in multiple sclerosis at the Center for Neurologic Diseases of the Brigham and Women's Hospital of Harvard Medical School.
Dr. Carolyn Schwartz is President & Chief Scientist at the not-for-profit DeltaQuest Foundation and Adjunct Research Professor of Medicine and Orthopaedic Surgery at the Tufts University School of Medicine. The 2016 recipient of the International Society for Quality of Life Research (ISOQOL) President's Award and ISOQOL Honorary Member since 2018, her interdisciplinary and methodological research focuses on understanding what patients can do to have an impact on the course of their disease and their well-being. In addition to development of theory and methods for response-shift research in quality of life, her work has spanned a number of diseases and conditions, and she has developed over 20 PRO measures. Dr. Schwartz earned a Bachelor's degree Magna Cum Laude in Psychology from UCLA, a Master's degree in Clinical Psychology at the University of Connecticut, and a Doctor of Science degree (Sc.D.) from the Harvard Chan School of Public Health with an emphasis on Behavioral Sciences, Biostatistics, and Immunology/Cancer Biology. She did her postdoctoral training in multiple sclerosis at the Center for Neurologic Diseases of the Brigham and Women's Hospital of Harvard Medical School.